Cargando…
Cytochrome P450 2C19 Polymorphism in Iranian Patients with Coronary Artery Disease
BACKGROUND: The polymorphisms of cytochrome P450 2C19 (CYP2C19) gene are major prognostic factors for the response to clopidogrel therapy in patients with coronary artery diseases (CAD). The CYP2C19*2 is the most important allele responsible for resistance to clopidogrel therapy. This study examined...
Autores principales: | Akhlaghi, Arash, Shirani, Shahin, Ziaie, Naghmeh, Pirhaji, Omid, Yaran, Majid, Shahverdi, Golnoosh, Sarrafzadegan, Nizal, Khosravi, Alireza, Khosravi, Elham |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Isfahan Cardiovascular Research Center, Isfahan University of Medical Sciences
2011
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3347856/ https://www.ncbi.nlm.nih.gov/pubmed/22577456 |
Ejemplares similares
-
The first Iranian recommendations on prevention, evaluation and management of high blood pressure
por: Noohi, Feridoun, et al.
Publicado: (2012) -
The impact of a community trial on the pharmacological treatment in the individuals with the metabolic syndrome: findings from the Isfahan Healthy Heart Program, 2001-2007
por: Gharipour, Mojgan, et al.
Publicado: (2012) -
The Effect of Parental Medical History on the Prevalence of Cerebrovascular Diseases in Their Children in an Iranian Population
por: Khosravi, Alireza, et al.
Publicado: (2018) -
The metabolic syndrome and associated lifestyle factors among the Iranian population
por: Gharipour, Mojgan, et al.
Publicado: (2015) -
Dietary inflammatory index in relation to severe coronary artery disease in Iranian adults
por: Dadaei, Zahra, et al.
Publicado: (2023)